Informatics Core C (Informatics/Biostatistics) The specialized research of the SPORE involves translational research integrating laboratory and clinical studies, interdisciplinary research, inter- project collaboration, and use of specialized resources like the Pathology and Tissue Resource by the projects. These endeavors require biostatistical experience, a facile means of communication, and the ability to share, analyze, and rigorously audit data, particularly clinical data. The Informatics Core was thus devised as a central and essential specialized resource that would be used by all the established and developmental projects of the SPORE as well as in its career development program to meet these needs. The collaborative interaction of UTSW and UTMDA in creating the University of Texas Lung Cancer SPORE makes the Informatics Core of even greater importance to facilitate inter-institutional integration. The purposes of the Informatics Core are as follows: l) To provide the statistical analysis required to achieve the specific aims of each project. 2) To assist in the design and analysis of new research arising from individual projects. 3) To facilitate electronic communication including the sharing of data and results between projects, cores and investigators and thus promote interdisciplinary, inter-project, and inter-institutional integration and collaboration. 4) To supervise and coordinate the collection, entry, and maintenance of data required for each project. 5) To provide for rigorous data management, quality assurance, auditing procedures, and confidentiality of clinical trials data. 6) To coordinate the data acquisition and biostatistical analysis and audit planning for the Internal Data Monitoring Committee. 7) To provide the above informatics support for the Developmental

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA070907-04
Application #
6198706
Study Section
Project Start
1999-09-08
Project End
2000-08-31
Budget Start
Budget End
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
City
Dallas
State
TX
Country
United States
Zip Code
75390
Ng, Patrick Kwok-Shing; Li, Jun; Jeong, Kang Jin et al. (2018) Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell 33:450-462.e10
Cascone, Tina; Gold, Kathryn A; Swisher, Stephen G et al. (2018) Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer. Ann Thorac Surg 105:418-424
Kim, Wanil; Shay, Jerry W (2018) Long-range telomere regulation of gene expression: Telomere looping and telomere position effect over long distances (TPE-OLD). Differentiation 99:1-9
Wang, Min; Abrams, Zachary B; Kornblau, Steven M et al. (2018) Thresher: determining the number of clusters while removing outliers. BMC Bioinformatics 19:9
Sinicropi-Yao, Sara L; Amann, Joseph M; Lopez, David Lopez Y et al. (2018) Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC. J Thorac Oncol :
Le, Xiuning; Puri, Sonam; Negrao, Marcelo V et al. (2018) Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC. Clin Cancer Res 24:6195-6203
Wang, Shidan; Chen, Alyssa; Yang, Lin et al. (2018) Comprehensive analysis of lung cancer pathology images to discover tumor shape and boundary features that predict survival outcome. Sci Rep 8:10393
Gomez, Daniel Richard; Byers, Lauren Averett; Nilsson, Monique et al. (2018) Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer. Oncotarget 9:14268-14284
Parra, Edwin R; Villalobos, Pamela; Mino, Barbara et al. (2018) Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non-Small Cell Lung Carcinoma. Appl Immunohistochem Mol Morphol 26:83-93
Yamauchi, Mitsuo; Barker, Thomas H; Gibbons, Don L et al. (2018) The fibrotic tumor stroma. J Clin Invest 128:16-25

Showing the most recent 10 out of 1059 publications